Hydrogen sulfide protects against amyloid beta-peptide induced neuronal injury via attenuating inflammatory responses in a rat model

Journal of Biomedical Research

Volumn 27, Issue 4, 2013, Pages 296-304

  Fan, Hao ^a   Guo, Yu ^a   Liang, Xiaoyan ^a   Yuan, Yibiao ^a   Qi, Xiaohong ^a   Wang, Min ^b   Ma, Jianhua ^b   Zhou, Hong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid; Cyclooxygenase 2; Hydrogen sulfide; Nuclear factor .B (NF .B)

Indexed keywords

EID: 84901000911     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.27.20120100     Document Type: Article

References (38)

1. Mattson MP, Maudsley S, Martin B. A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Res Rev 2004; 3: 445-64.
2. Ding BJ, Ma WW, He LL, Zhou X, Yuan LH, Yu HL, et al. Soybean isoflavone alleviates β-amyloid 1-42 induced inflammatory response to improve learning and memory ability by down regulation of Toll-like receptor 4 expression and nuclear factor-κB activity in rats. Int J Dev Neurosci 2011; 29: 537-42.
3. Esposito E, Cuzzocrea S. Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol 2010; 8: 228-42.
4. Saresella M, Calabrese E, Marventano I, Piancone F, Gatti A, Farina E, et al. A potential role for the PD1/PD-L1 pathway in the neuroinflammation of Alzheimer's disease. Neurobiol Aging 2012; 33: 624.e11-22.
5. Sy M, Kitazawa M, Medeiros R, Whitman L, Cheng D, Lane TE, et al. Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol 2011;178: 2811-22.
6. Myers RR. Planned change in the disability community. J Soc Work Disabil Rehabil 2006; 6: 93-109.
7. Kimura H. Hydrogen sulfide as a biological mediator. Antioxid Redox Signal 2005; 7: 778-80.
8. Zhang H, Zhi L, Moore PK, Bhatia M. Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1193-L1201.
9. Umemura K, Kimura H. Hydrogen sulfide enhances reducing activity in neurons: neurotrophic role of H2S in the brain? Antioxid Redox Signal 2007; 9: 2035-41.
10. Hu LF, Wong PT, Moore PK, Bian JS. Hydrogen sulfide attenuates lipopolysaccharide-induced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 2007; 100: 1121-8.
11. Lu M, Hu LF, Hu G, Bian JS. Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake. Free Radic Biol Med 2008; 45: 1705-13.
12. Hu LF, Lu M, Wu ZY, Wong PT, Bian JS. Hydrogen sulflde inhibits rotenone-induced apoptosis via preservation of mitochondrial function. Mol Pharmacol 2009; 75: 27-34.
13. Liu YY, Bian JS. Hydrogen sulfide protects amyloid-beta induced cell toxicity in microglia. J Alzheimers Dis 2010; 22: 1189-1200.
14. Xuan Aiguo, Long DH, Li JH, Ji WD, Zhang M, Hong LP, et al. Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer's disease. J Neuroinflammation 2012; 9: 202.
15. Wang R. Physiological implications of hydrogen sulfide: a whiffexploration that blossomed. Physiol Rev 2012; 92: 791-896.
16. Hu LF, Lu Ming, Tiong CX, Dawe Gavin S., Hu G and Bian JS. Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models. Aging Cell 2010; 9: 135-46.
17. Biagini G, D'Arcangelo G, Baldelli E, D'Antuono M, Tancredi V, Avoli M. Impaired activation of CA3 pyramidal neurons in the epileptic hippocampus. Neuromolecular Med 2005; 7, 325-42.
18. Hashimoto T, Adams KW, Fan Z, McLean PJ, Hyman BT: Characterization of oligomer formation of amyloid-beta peptide using a split-luciferase complementation assay. J Biol Chem 2011; 286: 27081-91.
19. Shin RW, Ogino K, Kondo A, Saido TC, Trojanowski JQ, Kitamoto T, et al. Amyloid beta-protein (Abeta) 1-40 but not Abeta1-42 contributes to the experimental formation of Alzheimer disease amyloid fibrils in rat brain. J Neurosci 1997; 17: 8187-93.
20. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, et al. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a] pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. J Pharmacol Exp Ther 2006; 317: 1079-87.
21. Zou K, Kim D, Kakio A, Byun K, Gong JS, Kim J, et al. Amyloid beta-protein (Abeta)1-40 protects neurons from damage induced by Abeta1-42 in culture and in rat brain. J Neurochem 2003; 87: 609-19.
22. Roberson ED, Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science 2006; 314: 781-4.
23. Sheng JG, Bora SH, Xu G, Borchelt DR, Price DL, Koliatsos VE. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis 2003; 14: 133-45.
24. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005; 25: 8843-53.
25. Liu WC, Ding WL, Gu HY, Chen MF, Hu JJ. Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist. Neurosci Bull 2007; 23: 271-6.
26. McGeer EG, McGeer PL. Neuroin'ammation in Alzheimer's disease and mild cognitive impairment: a'eld in its infancy. J Alzheimers Dis 2010; 19: 355-61.
27. Ownby RL. Neuroinflammation and cognitive aging. Curr Psychiatry Rep 2010; 12: 39-45.
28. Deng XH, Ai WM, Lei DL, Luo XG, Yan XX, Li Z. Lipopolysaccharide induces paired immunoglobulin-like receptor B (PirB) expression, synaptic alteration, and learning-memory deficit in rats. Neuroscience 2012; 209: 161-70.
29. Morales I, Farías G, Maccioni RB. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 2010; 17: 202-4.
30. Angelopoulos P, Agouridaki H, Vaiopoulos H, Siskou E, Doutsou K, Costa V, et al. Cytokines in Alzheimer's disease and vascular dementia. Int J Neurosci 2008; 118: 1659-72.
31. Forlenza OV, Diniz BS, Talib LL, Mendonça VA, Ojopi EB, Gattaz WF, et al. Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2009; 28: 507-12.
32. Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease-a double-edged sword. Neuron 2002; 35: 419-32.
33. Ghilardi JR, Svensson CI, Rogers SD, Yaksh TL, Mantyh PW. Constitutive spinal cyclooxygenase-2 participates in the initiation of tissue injury-induced hyperalgesia. J Neurosci 2004; 24: 2727-32.
34. Burian M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther 2005; 107: 139-54.
35. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA, Kaltschmidt C. Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci U S A 1997; 94: 2642-7.
36. Kitamura Y, Shimohama S, Ota T, Matsuoka Y, Nomura Y, Taniguchi T. Alteration of transcription factors NF-kappaB and STAT1 in Alzheimer's disease brains. Neurosci Lett 1997; 237: 17-20.
37. Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 2005; 280: 40364-474.
38. Gong QH, Wang Q, Pan LL, Liu XH, Huang H, Zhu YZ. Hydrogen sulfide attenuates lipopolysaccharide-induced cognitive impairment: a pro-inflammatory pathway in rats. Pharmacol Biochem Behav 2010; 96: 52-8.